Physician profile
Michael A Fuller
NPI 1427228154
$3,477.94
in general payments reported to CMS, 2019-2025
11 companies · $686 in 2025
The $686 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,340 · 2020: $21.64 · 2021: $41.56 · 2022: $186 · 2023: $125 · 2024: $77.21 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $2,326.00 | 2019 | |
| Depuy Synthes Sales INC. | $572.01 | 2022-2025 | Healix Knotless Peek, Vapr, Dynacord |
| Zimmer Biomet Holdings, INC. | $207.89 | 2020-2022 | |
| Miach Orthopaedics, INC. | $176.43 | 2025 | |
| Stryker Corporation | $39.68 | 2025 | Pangea, Variax |
| Skeletal Dynamics INC | $37.89 | 2024 | Align, Implate, Ijs |
| Vericel Corporation | $35.09 | 2019-2025 | Maci |
| Ethicon US, LLC | $27.69 | 2025 | Surgiflo Hemostatic Matrix |
| Pacira Pharmaceuticals Incorporated | $24.29 | 2025 | Exparel |
| Globus Medical, INC. | $16.24 | 2023 | Clavicular Fracture Fixation |
| Bioventus LLC | $14.73 | 2025 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.